Entasis Therapeutics Holdings Inc. (ETTX) Social Stream
Entasis Therapeutics Holdings Inc (ETTX) Price Targets From Analysts
Use the tables below to see what analysts covering Entasis Therapeutics Holdings Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 4 | $9 | $5 | $6.75 | $1.87 | 260.96% |
| 2022-03-04 | 4 | $9 | $5 | $6.75 | $1.87 | 260.96% |
| 2022-03-08 | 4 | $7 | $1.8 | $3.9 | $1.87 | 108.56% |
The Trend in the Analyst Price Target
ETTX's average price target has moved down $2.35 over the prior 22 months.
ETTX reports an average of 154.51% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-05 | 6 | 9 | 5.0 | 6.0 | 2.44 | 145.9% |
| 2021-07-24 | 6 | 9 | 5.0 | 6.0 | 2.50 | 140% |
| 2021-09-11 | 4 | 9 | 5.0 | 6.0 | 2.78 | 115.83% |
| 2021-09-20 | 4 | 9 | 5.0 | 6.0 | 3.45 | 73.91% |
| 2022-03-08 | 4 | 7 | 1.8 | 3.9 | 1.65 | 136.36% |
ETTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
ETTX's average broker recommendation rating worsened by 1 over the prior 120 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Entasis Therapeutics Holdings Inc fares relative to all US stocks, note that its average analyst price target is higher than 10.17% of that group.
- ETTX has a lower variance in analysts' estimates than -167.69% of all US stocks.
- Entasis Therapeutics Holdings Inc's number of analysts covering the stock is higher than 68.94% of Pharmaceutical Products stocks.
- In terms of how Entasis Therapeutics Holdings Inc fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is greater than 180.33% of that group.
In the Pharmaceutical Products industry, ETON, EQ, and ENVB are the three stocks most similar to Entasis Therapeutics Holdings Inc regarding the price target and analyst recommendation information presented here.
Is ETTX a Buy, Hold or Sell? See the POWR Ratings now!